3,809
Participants
Start Date
February 29, 2008
Primary Completion Date
May 31, 2010
Study Completion Date
May 31, 2010
insulin aspart
Start dose and frequency to be prescribed by the physician as a result of the normal clinical evaluation
biphasic insulin aspart 30
Start dose and frequency to be prescribed by the physician as a result of the normal clinical evaluation
insulin detemir
Start dose and frequency to be prescribed by the physician as a result of the normal clinical evaluation
Novo Nordisk Investigational Site, Bratislava
Lead Sponsor
Novo Nordisk A/S
INDUSTRY